mixedAnecdotalApr 9, 2026
Consumer explainer interest
GHK-Cu is showing up in plain-English peptide media alongside BPC-157 and TB-500, especially around skin and cosmetic framing.
Apple Podcastsmedium confidencepodcast
Source GHK-Cu (Copper Peptide)
GHK-Cu · Copper Tripeptide-1
Skin & HairTissue RepairNot ApprovedPhase IIResearchSubQTopical
Popular for:Skin rejuvenation, wound healing, collagen synthesis, hair growth
1
Registered Trials
1
Trial Publications
152
PubMed References
Phase II
Evidence Level
Overview
GHK-Cu (Glycyl-L-Histidyl-L-Lysine Copper) is a naturally occurring copper-binding tripeptide found in human plasma, saliva, and urine. The short version: people usually care about it for skin rejuvenation, wound healing, collagen synthesis, hair growth, but the strength of the evidence depends heavily on indication and study type.
GHK-Cu (Glycyl-L-Histidyl-L-Lysine Copper) is a naturally occurring copper-binding tripeptide found in human plasma, saliva, and urine. It was first identified in 1973 by Dr. Loren Pickart. It declines with age — plasma levels drop from ~200 ng/mL at age 20 to ~80 ng/mL by age 60 — making it a key target for anti-aging interventions.
**Mechanism of Action: **GHK-Cu acts as a signaling molecule that modulates gene expression across multiple pathways. It stimulates collagen synthesis, promotes decorin production, increases elastin and glycosaminoglycan synthesis, supports angiogenesis, has antioxidant activity (upregulates superoxide dismutase, blocks ferritin iron release), and activates wound healing through attraction of macrophages and mast cells. Gene profiling studies show it can reset the expression of approximately 4,000 human genes toward a healthier state.
**Originally developed for: **Wound healing research. Dr. Pickart discovered that GHK-Cu in old human plasma could restore the synthetic capacity of liver tissue, leading to decades of skin regeneration and anti-aging research.
Research Snapshot
What the evidence says
Phase IIGHK-Cu (Copper Peptide) currently shows 1 registered trials from ClinicalTrials.gov, 1 PubMed trial publications (1 RCT-tagged), and 152 PubMed references matching the stored source query. Treat PubMed references as literature surface area, not a count of clinical trials.
Known vs uncertain
Known signals
- 1 registered trials are tracked from ClinicalTrials.gov intervention records.
- 1 PubMed clinical-trial publications are indexed.
- 1 PubMed randomized controlled trial publications are indexed.
- 152 PubMed references are tracked separately from trial counts and can include animal, in-vitro, review, mechanism, or clinical records.
Open questions
- Evidence strength may vary by indication, route, formulation, and population.
- Public anecdotes can highlight interest or concern but do not establish clinical efficacy.
- Regulatory status and compounding access can change independently from the research literature.
Mechanism of Action
Origin & biochemistry. GHK is a naturally occurring tripeptide that binds copper(II) with high affinity, forming GHK-Cu.
Key Research Benefits
Primary Benefits:
Skin regeneration — Stimulates collagen I and III synthesis, elastin production, and glycosaminoglycans. Clinically shown to improve skin firmness, reduce fine lines, and improve skin clarity (Pickart et al., 2012)
Wound healing — Accelerates wound closure, reduces scar formation, and attracts immune cells to repair sites (PMC4508379)
Hair growth — Stimulates hair follicle growth, increases follicle size, and may counteract DHT-related thinning
Antioxidant — Upregulates superoxide dismutase (SOD) and blocks damaging iron release from ferritin
Secondary/Emerging Benefits:
Anti-aging gene modulation — Resets ~4,000 genes toward youthful expression patterns (Pickart et al., 2015)
COPD — Gene data suggests potential benefit for chronic obstructive pulmonary disease
Anti-inflammatory — Reduces pro-inflammatory cytokines including IL-6 and TNF-alpha
Bone regeneration — Promotes osteoblast activity and bone repair in animal models
Clinical Evidence Summary
Research Pipeline
Preclinical
Animal
Phase I
Phase II
Phase III
Approved
1
Registered Trials
1
Trial Publications
1
RCT Publications
152
PubMed References
ClinicalTrials.govPubMed ESearchCurated alias queryChecked May 3, 2026
Registered trials are ClinicalTrials.gov intervention records. Trial publications are PubMed records tagged as clinical trials or randomized controlled trials. PubMed references are broader source-query matches and can include animal studies, in-vitro work, reviews, mechanism papers, and trial publications.
1
Registered trials
1
Trial publications
1
RCT publications
152
PubMed references
13
Reviews
0
Meta-analyses
Registered trials source
Jun 1, 2026
GHK-Cu
Uses curated ClinicalTrials.gov intervention aliases to avoid misleading registry matches.
View sourcePublication counts source
May 3, 2026
GHK-Cu, glycyl-l-histidyl-l-lysine, glycyl-histidyl-lysine, Copper Tripeptide-1
Uses common GHK-Cu chemical names instead of the display label.
View source- Pickart et al. (1973-2015) — Foundational research spanning decades. Identified GHK-Cu in human plasma, demonstrated collagen synthesis, wound healing, and gene modulation effects.
- PMC4508379 — Comprehensive review: "GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration." Detailed analysis of mechanisms and skin applications.
- PMC6073405 — "Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data." Showed GHK-Cu modulates ~4,000 genes toward healthier expression.
- Clinical studies in cosmetic applications have demonstrated measurable improvements in skin thickness, firmness, and wrinkle reduction.
> Clinical trial status: GHK-Cu has been used in cosmetic products for decades with good safety data. Injectable use for systemic anti-aging is newer and less clinically validated. Most evidence is preclinical + cosmetic trial data.
Key PubMed References
152 PubMed references · showing top 25 by relevance
View all on PubMedTherapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions.
Review
Rahman OF, Lee SJ, Seeds WA · Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews · 2026
PMID: 41490200Glycyl-L-histidyl-L-lysine-Cu2(GHK-Cu) Attenuates CuSOor LPS induced-inflammation in Zebrafish larvae model.
Review
Hu J, Zhang C, Wang F · European journal of pharmacology · 2026
PMID: 41997403An injectable hydroxyapatite microsphere filler loaded with GHK-Cu tripeptide for anti-Inflammatory and antioxidant.
In Vitro
Hu D, Zhang X, Gong S, et al. · Colloids and surfaces. B, Biointerfaces · 2025
PMID: 40716276Topically applied GHK as an anti-wrinkle peptide: Advantages, problems and prospective.
Review
Mortazavi SM, Mohammadi Vadoud SA, Moghimi HR · BioImpacts : BI · 2025
PMID: 39963574Food-Derived Tripeptide-Copper Self-Healing Hydrogel for Infected Wound Healing.
Review
Chen H, Yang P, Xue P, et al. · Biomaterials research · 2025
PMID: 39902373Anecdotes & Sentiment
Public discussion, not clinical evidence
This section summarizes what people are talking about in public sources. It can be useful for spotting questions, hype cycles, and recurring concerns, but it is separate from the evidence sections above.
Side Effects & Safety
**Common Side Effects:** - Mild skin irritation or redness at application/injection site - Temporary skin flushing - Generally very well tolerated — side effects are rare **Rare but Serious Risks:** - Copper overload — Theoretically possible with excessive injectable use, though risk is negligible at recommended doses - Wilson's disease patients must avoid GHK-Cu due to impaired copper metabolism > Contraindications: Wilson's disease (copper storage disorder).
Common Side Effects:
Mild skin irritation or redness at application/injection site
Temporary skin flushing
Generally very well tolerated — side effects are rare
Rare but Serious Risks:
Copper overload — Theoretically possible with excessive injectable use, though risk is negligible at recommended doses
Wilson's disease patients must avoid GHK-Cu due to impaired copper metabolism
> Contraindications: Wilson's disease (copper storage disorder). Caution in individuals with liver disease or impaired copper metabolism. Not recommended during pregnancy/breastfeeding.
Known Interactions
No curated interaction entry is live for GHK-Cu (Copper Peptide) yet.
Until the interaction table is fully populated, use the interaction checker and related peptides below to explore adjacent compounds and likely research pairings.
Comparison Pages
Frequently Asked Questions
Research Disclaimer
This page is for research and educational purposes only. The information presented is based on published scientific literature and does not constitute medical advice, diagnosis, or treatment recommendations. Regulatory status can vary by compound, formulation, indication, and jurisdiction. Check official labeling, registry records, and qualified professional guidance before making any health-related decision. The studies referenced are linked to their original PubMed sources for verification.